Seborrheic dermatitis is caused by an inflammatory reaction to a common yeast that lives on everyone’s skin, combined with individual differences in oil production, immune response, and skin barrier function. About 4.4% of the global population has it, with adults affected more often (5.6%) than children (3.7%). It’s not a hygiene problem or an infection you can catch. It’s the result of several biological systems interacting in ways that make some people’s skin react while others remain unaffected.
The Role of Yeast on Your Skin
The central player in seborrheic dermatitis is a group of fungi called Malassezia, specifically two species: M. globosa and M. restricta. These yeasts live on everyone’s skin, clustering in oily areas like the scalp, face, and chest. In most people, they cause no issues. But in people with seborrheic dermatitis, the skin’s immune system overreacts to these organisms and their byproducts.
Malassezia yeasts depend on lipids (fats) to survive. They produce enzymes called lipases that break down the oils on your skin’s surface. This process releases compounds, including arachidonic acid, that can trigger inflammation in the surrounding tissue. The yeasts also generate reactive oxygen species and other toxic metabolites that irritate the skin directly. So the inflammation in seborrheic dermatitis is partly an immune response and partly a direct chemical irritation from the waste products these organisms leave behind.
Sebum and Skin Lipid Imbalances
People with seborrheic dermatitis don’t necessarily produce more oil than everyone else, but their skin’s lipid composition is different. Research has found that affected skin tends to have higher levels of cholesterol and lower levels of squalene, a protective lipid, compared to healthy skin. More recent studies show that overall skin surface lipid levels are higher in people with the condition, and that this correlates with symptom severity.
This matters because the excess sebum disrupts the normal shedding process of your outer skin layer. Skin cells that should flake off invisibly instead clump together, forming the visible scales and flakes characteristic of the condition. The altered lipid environment also creates a more hospitable habitat for Malassezia, feeding the cycle of yeast growth and inflammation. Notably, someone with normal sebum production can still develop seborrheic dermatitis. It’s not just about quantity of oil but about how the skin and the yeast interact.
Immune System Vulnerability
Your immune system’s strength plays a major role in how severe seborrheic dermatitis becomes. The clearest evidence comes from people living with HIV, where the condition is far more common and often dramatically worse. In HIV-positive individuals, seborrheic dermatitis appears early in the disease course, even when immune cell counts are still relatively high (above 400 CD4 cells). In severe cases, it can spread across the entire body rather than staying confined to the usual areas.
This pattern suggests that even modest shifts in immune function can tip the balance. The immune system normally keeps Malassezia populations in check and modulates the inflammatory response to their metabolites. When that regulation weakens, the reaction intensifies. This also helps explain why flares often coincide with periods of illness, fatigue, or other immune stressors.
Genetics and Inherited Susceptibility
There is a genetic component to seborrheic dermatitis, though it’s complex. Researchers have identified at least 11 gene mutations or protein deficiencies linked to the condition. Most of these genes fall into two categories: those involved in immune response and those that control how the outer layer of skin develops and maintains itself. If your body produces a slightly different inflammatory response to Malassezia, or if your skin barrier is inherently less resilient, you’re more likely to develop the condition. This is why seborrheic dermatitis often runs in families, even though no single “seborrheic dermatitis gene” has been identified.
Hormones and Age-Related Patterns
Seborrheic dermatitis follows a distinctive pattern across the lifespan that points to hormonal influence. It first appears in newborns (as cradle cap), largely disappears during childhood, then returns during adolescence and persists into adulthood. In infants, the likely trigger is maternal hormones still circulating in the baby’s body after birth. These hormones stimulate the sebaceous glands, producing an oily environment on the scalp that promotes yeast growth and prevents dead skin cells from shedding normally. The condition resolves on its own as those maternal hormones clear the infant’s system.
Its return during puberty, when androgen production ramps up and sebaceous glands become more active, reinforces the hormonal connection. This bimodal pattern, appearing when hormonal stimulation of oil glands is highest, is one of the strongest pieces of evidence for hormones as a root cause.
Stress and Skin Barrier Breakdown
Psychological stress is one of the most commonly reported triggers for flares, and the biological pathway is becoming clearer. Your skin contains its own version of the stress hormone system (the HPA axis) that mirrors the one in your brain. When you’re under chronic stress, elevated cortisol levels directly compromise the skin barrier in several ways: they reduce the production of protective lipids, slow skin cell turnover, and weaken the structural connections between cells in the outermost layer of skin.
The result is a skin barrier that loses moisture more easily and becomes more permeable to irritants. Chronic stress also suppresses the skin’s innate immune defenses. For someone already prone to seborrheic dermatitis, this creates the perfect conditions for a flare: a weakened barrier, reduced immune surveillance, and the Malassezia population poised to take advantage. Sleep deprivation compounds the problem, further inhibiting the lipid production that keeps the skin barrier intact.
Cold Weather and Low Humidity
Seborrheic dermatitis flares are significantly more common in colder months. A study examining the relationship between climate and flare frequency found strong inverse correlations between temperature and the rate of seborrheic dermatitis, meaning lower temperatures were associated with more cases. Low humidity and reduced UV exposure showed similar patterns.
Cold, dry air disrupts the skin barrier directly, stripping moisture and creating micro-cracks that allow irritants to penetrate. Meanwhile, reduced sunlight appears to give Malassezia an advantage, since UV exposure has been shown to suppress the yeast’s activity on the skin. This is why many people with seborrheic dermatitis notice their symptoms improve during summer and worsen in winter, particularly in temperate climates with distinct seasons.
Neurological Conditions
People with Parkinson’s disease develop seborrheic dermatitis at notably higher rates than the general population. The explanation is surprisingly mechanical. Parkinson’s causes rigidity and reduced facial movement (called hypomimia), which means the skin on the face stays relatively still. One leading hypothesis is that this immobility allows sebum to pool on the skin’s surface rather than being naturally redistributed through normal muscle movement and facial expressions. The stagnant layer of oil feeds Malassezia growth. Supporting this theory, when Parkinson’s medications improve a patient’s motor symptoms, their seborrheic dermatitis often improves too, not because of any direct skin effect but because the patient is moving their face more.
Medications That Can Trigger Flares
A number of medications are known to induce seborrheic dermatitis or worsen existing cases. Lithium, commonly prescribed for bipolar disorder, is one of the most well-documented culprits. Certain antipsychotic medications, including haloperidol and chlorpromazine, can also trigger flares. The anti-anxiety medication buspirone, the chemotherapy drug fluorouracil, and interferon alfa (used for hepatitis and some cancers) are on the list as well. If you notice your skin worsening after starting a new medication, the timing may not be coincidental.